Last reviewed · How we verify
NCT05415527: OPTIMOVA
Evaluation of Pretreatment Sarcopenia in Patients With Inoperable High-grade Ovarian Carcinoma as Part of Optimised Management
NA trial testing Presence of sarcopenia evaluated prior to neoadjuvant chemotherapy and during chemotherapy as part of optimised management(dietician and APA). in Ovarian Carcinoma in 25 participants. Participants enrolled and being followed up; not accepting new ones.
10 June 2027
Quick facts
| Lead sponsor | Institut Bergonié |
|---|---|
| Phase | NA |
| Status | Active, enrolled |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | prevention |
| Enrollment | 25 |
| Start date | 11 June 2022 |
| Primary completion | 10 June 2027 |
| Estimated completion | 10 June 2028 |
| Sites | 1 location across France |
Drugs / interventions tested
- Presence of sarcopenia evaluated prior to neoadjuvant chemotherapy and during chemotherapy as part of optimised management(dietician and APA).
Conditions studied
- Ovarian Carcinoma — all drugs for Ovarian Carcinoma →
Sponsor
Institut Bergonié — full company profile →
Who can join
18 and older, female only, with Ovarian Carcinoma. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Prospective, monocentric study evaluating the presence of sarcopenia prior to neoadjuvant chemotherapy and during chemotherapy as part of optimised management.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Multimodal Prehabilitation in Indian Women with Advanced Ovarian Cancer: Enhancing Nutritional, Psychological, and Surgical Recovery.
Rajan S, Yadav RK, Kaur P, Dhamija E, et al · · 2025 · PMID 41459872 · DOI 10.31557/apjcp.2025.26.12.4575
Verify or expand the search:
- PubMed search for NCT05415527
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Ovarian Carcinoma
Currently open trials in the same condition.
- NCT07282158 — Adapted Helping Ovarian Cancer Patients Cope Intervention to Address Burnout for Gynecologic Oncology Clinicians · NA · recruiting
- NCT07280312 — Ultrasound Microvessel Imaging for the Evaluation of Ovarian and Adnexal Lesions · NA · recruiting
- NCT07285044 — The Cancer Connected Access and Remote Expertise Beyond Walls Program to Provide In-Home Cancer Treatment and Improve Tr · Phase 2 · recruiting
- NCT06964009 — DT2216 + Paclitaxel in Platinum-Resistant Ovarian Cancer · Phase 1 · recruiting
- NCT07118176 — Determining the Biodistribution of an Imaging Tracer (68Ga-FAPi-46) in Patients With Solid Tumors or Hematologic Cancers · Phase 1 · recruiting
Other Institut Bergonié trials
Trials by the same sponsor.
- NCT06084689 — Targeting MDMD and PD1 in Tumors With Tertiary Lymphoid Structures · Phase 2 · withdrawn
- NCT06700057 — Clinical and Dosimetric Study of Patients Treated With 177Lu-PSMA-617 for Prostate Cancer. · recruiting
- NCT05690828 — Evaluation of Cognitive Management for Chemobrain in Patients Treated for Breast Cancer. · NA · active not recruiting
- NCT04912687 — Implementing Circulating Tumor DNA Analysis at Initial Diagnosis to Improve Management of Advanced NSCLC Patients · NA · completed
- NCT05070897 — Health Literacy and Digital Health in Cancer Patients. · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05415527 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Institut Bergonié
- Last refreshed: 29 January 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05415527.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing